Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Plant compounds may boost antiviral treatments.

Immune-epithelial interactions are crucial for tissue repair, but unchecked can cause diseases.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Patients with skin immune diseases need better education on UV protection to improve compliance.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

γδT cells can protect hair follicles from alopecia areata and promote hair regrowth.

Finasteride increases CD8+ T cells in BPH tissues.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

Vaccination is crucial for psoriasis patients on immunosuppressive therapy to manage COVID-19 risks.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Intradermal testing can better detect corticosteroid allergies than patch testing.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

New, effective treatments for alopecia areata require innovative approaches targeting the immune system.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

AS101 reduces hair loss from chemotherapy.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

Betamethasone injections are more effective than Clobetasol for treating alopecia areata in children.

A cancer patient's hair became permanently curly after treatment with nivolumab.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.